OR WAIT null SECS
January 14, 2025
The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Mark Jara, founder and CTO, RxS, shares his inspiration behind designing SampleHub.
January 13, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Mark Jara, founder and CTO, RxS, explains the value of an online portal that offers logistics flexibility.
January 10, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Mark Jara, founder and CTO, RxS, describes the progression of the sample distribution process.
January 09, 2025
The program intends to address supply chain challenges surrounding product safety, traceability, and counterfeiting.
December 24, 2024
The Drug Supply Chain Security Act was a major coverage area for Pharma Commerce in 2024.
December 23, 2024
How will supply chains in the space continue to develop?
December 20, 2024
In the fifth part of this roundtable discussion, subject matter experts discuss the role that various GS1 initiatives have played, and provide a breakdown of stakeholders who have benefitted greatly from RFID.
As a result, the provider increases its involvement in the country’s pharma sector.
December 17, 2024
The 430,000 square-foot finished production facility will house multiple product types within the rare disease sector, including hemophilia.